How is Myelofibrosis diagnosed? Discover the steps from blood tests and bone marrow biopsy to genetic risk scoring and staging at Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and Evaluation
Getting a correct diagnosis for a rare blood cancer like Myelofibrosis can be a complex journey. Many patients arrive at Liv Hospital after receiving unclear results elsewhere or simply knowing that something is wrong with their blood counts. Because this condition shares many features with other bone marrow disorders, accurate identification requires a precise and multi-step approach.
At Liv Hospital Hematology and Bone Marrow Transplant Center, we do not just rely on a single test. We combine advanced imaging, molecular genetics, and expert pathology to build a complete picture of your health. Our goal is to move you from uncertainty to a clear, actionable plan as quickly as possible. The evaluation process is designed to answer two critical questions. Do you definitely have Myelofibrosis, and exactly how advanced is it?
The process begins with a thorough physical exam. Your hematologist will look for visible signs of the disease, primarily an enlarged spleen (splenomegaly). By gently pressing on the upper left abdomen, doctors can detect if the spleen has grown to compensate for the failing bone marrow.
We also review your medical history for “constitutional symptoms” like night sweats, bone pain, and weight loss. These are not just complaints; they are critical data points used to calculate your risk score later.
Blood tests are often the first indicator that prompts further investigation. A Complete Blood Count is the standard starting point. In Myelofibrosis, this test typically reveals a chaotic picture. You may have low red blood cell counts, which is anemia, while your white blood cells and platelets might be abnormally high or low.
However, the numbers alone are not enough. The shape of the cells tells a much more important story.
Our pathologists perform a Peripheral Blood Smear by examining a drop of your blood under a microscope. This simple visual check is often the strongest clue for diagnosis. In Myelofibrosis, the red blood cells are forced out of the scarred bone marrow before they are fully mature. As they squeeze through the fibrotic tissue, they become shaped like teardrops. These teardrop cells, scientifically known as dacrocytes, are a classic hallmark of the disease. The presence of immature blood cells in the circulation, called leukoerythroblastosis, is another key sign that the bone marrow is under stress.
While physical exams are useful, advanced imaging provides precise measurements for staging.
The only way to confirm Myelofibrosis with absolute certainty is to examine the marrow directly. This “gold standard” procedure involves two steps performed simultaneously on the hip bone:
At Liv Hospital, we prioritize your comfort by using local anesthesia and sedation options to ensure the procedure is as pain-free as possible.
Once the cells are collected, we look deep inside them to find the genetic driver of the disease. Understanding your genetic mutation is essential because it influences both your prognosis and your treatment options.
We test for three primary gene mutations:
If you do not have any of these three, you are considered Triple Negative. Patients with Triple Negative status often have a different disease course and may need more aggressive monitoring. We also use Next-Generation Sequencing to look for other high-risk mutations that might suggest the disease is progressing faster than usual.
Diagnosing the disease is only half the battle. The second half is determining your “Risk Score,” which guides your treatment plan.
We use the DIPSS Plus system to predict how the disease will behave. Points are assigned based on age, symptoms, and blood counts to place you in a risk category:
This evaluation is the most critical part of your visit, giving you a clear roadmap for your future care.
Speed and accuracy define our program. While some systems take weeks for genetic results, our integrated laboratories provide rapid reports. For international patients, we offer comprehensive packages including the biopsy, genetic sequencing, and English-translated reports, ensuring you leave with total confidence in your plan.
Send us all your questions or requests, and our expert team will assist you.
Most patients feel pressure rather than sharp pain. We use local anesthesia to numb the area completely and offer sedation to help you relax. The procedure is quick and usually over in less than 20 minutes.
It is possible to have Myelofibrosis without the common JAK2, CALR, or MPL mutations. This is called Triple Negative Myelofibrosis. In these cases, the diagnosis relies heavily on the bone marrow biopsy results and physical symptoms.
It changes the treatment approach entirely. Prefibrotic patients often do not need aggressive treatment and can live for many years with minimal intervention. Misdiagnosing early-stage MF as advanced MF could lead to unnecessary chemotherapy.
If you are stable, we recommend a check-up every 3 to 6 months. If symptoms worsen, immediate re-evaluation is needed.
Yes. It is a minor procedure. You may feel slight soreness, but it does not restrict air travel.
Your Comparison List (you must select at least 2 packages)
